GLP-1 body composition research: lean mass in the trial data
Weight lost in GLP-1 trials is not all fat. DXA data, the STEP 1 trial and the BELIEVE combination study show lean mass is a measurable part of the picture.
Read article →For research use only — not for human consumption
Journal topic
Research on incretin receptors, body composition endpoints, and metabolic signaling.
Weight lost in GLP-1 trials is not all fat. DXA data, the STEP 1 trial and the BELIEVE combination study show lean mass is a measurable part of the picture.
Read article →GLP-1 research now reaches well beyond weight. Notes on where the field is heading and the variables that make combination studies hard to control.
Read article →GLP-1 is often described as an appetite signal. Receptor expression data from cardiac and brain tissue suggests the signal reaches much further.
Read article →Mandatory research disclaimer
All materials on this site are sold as laboratory reagents for research use only. They are not drugs, foods, cosmetics, dietary supplements, or medical devices, and are not for human or veterinary use of any kind.
Senna Research makes no claims of safety or efficacy and provides no usage, dosing, or preparation guidance; we publish analytical data only.
These materials have not been evaluated or approved by the U.S. Food and Drug Administration for any use.